Toremifene citrate | B1049

Toremifene citrate is a selective estrogen receptor modulator (SERM) that is widely being used as endocrine therapy for estrogen receptor positive breast cancer. Toremifene citrate is known to increase bone mineral density in prostate cancer patients undergoing androgen deprivation therapy.

Toremifene citrate is a selective estrogen receptor modulator (SERM) that is widely being used as endocrine therapy for estrogen receptor positive breast cancer. Toremifene citrate is known to increase bone mineral density in prostate cancer patients undergoing androgen deprivation therapy.

B1049 | Toremifene citrate DataSheet

Alternate Name/Synonyms: (Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine, Acapodene, Fareston, GTx 006, Z-Toremifene

Appearance: White to off-white solid

Formulation: N/A

CAS Number: 89778-27-8

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₂₆H₂₈ClNO.C₆H₈O₇

Molecular Weight: 598.08

Cell-Permeable?: Yes

Purity: ≥98% by HPLC

Solubilities: DMSO (>10 mg/ml)

Handling: Protect from air and moisture

Country of Origin: USA

Tag Line: A selective estrogen receptor modulator (SERM)

MDL Number: MFCD01729016

PubChem CID: 3005572

SMILES: CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

InChi: InChI=1S/C26H28ClNO.C6H8O7/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-16H,17-20H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/b26-25-;

InChi Key: IWEQQRMGNVVKQW-OQKDUQJOSA-N